Board 2019-2022
 Section Chair Ludger Klimek Germany |
Section Secretary |
-
Interview with Philippe Gevaert, Ghent University
Philippe Gevaert talks about the importance of interaction between ENT specialists and immunotherapy and biologics specialists, and highlights the importance of understanding who to treat with these medications. “”It is crucial to take a good product for the right patient and to |
-
-
Recommended reads
Auge et al - EAACI position paper on standardization of nasal allergen challenges
Roberts et al - EAACI Guidelines on allergen immunotherapy: Allergic rhinoconjunctivitis
Hellings et al - Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology
Hellings et al - Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUROREA-ARIA-EPOS-AIRWAYS ICP statement
Pfaar et al - Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper
Last updated 17 November 2021